- 現金殖利率: 4.66%、總殖利率: 4.66%、5年平均現金配發率: 87.05%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 1.94 | 17.58 | 1.65 | 10.0 | 0.00 | 0 | 85.05 | -6.44 | 0.00 | 0 | 85.05 | -6.44 |
2022 (9) | 1.65 | -6.25 | 1.50 | -6.25 | 0.00 | 0 | 90.91 | 0.0 | 0.00 | 0 | 90.91 | 0.0 |
2021 (8) | 1.76 | -28.16 | 1.60 | -20.0 | 0.00 | 0 | 90.91 | 11.36 | 0.00 | 0 | 90.91 | 11.36 |
2020 (7) | 2.45 | 11.87 | 2.00 | 5.26 | 0.00 | 0 | 81.63 | -5.91 | 0.00 | 0 | 81.63 | -5.91 |
2019 (6) | 2.19 | -3.95 | 1.90 | 2.7 | 0.00 | 0 | 86.76 | 6.92 | 0.00 | 0 | 86.76 | 6.92 |
2018 (5) | 2.28 | -4.6 | 1.85 | 2.78 | 0.00 | 0 | 81.14 | 7.74 | 0.00 | 0 | 81.14 | -17.48 |
2017 (4) | 2.39 | -2.85 | 1.80 | 0 | 0.55 | 0 | 75.31 | 0 | 23.01 | 0 | 98.33 | 0 |
2016 (3) | 2.46 | -1.2 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
---|---|---|---|---|---|---|---|---|---|
24Q3 (20) | 0.47 | 34.29 | 6.82 | 0.38 | -24.0 | 8.57 | 0.96 | 95.92 | -23.2 |
24Q2 (19) | 0.35 | 150.0 | -35.19 | 0.50 | 233.33 | 19.05 | 0.49 | 250.0 | -39.51 |
24Q1 (18) | 0.14 | -80.0 | -48.15 | 0.15 | -72.22 | -21.05 | 0.14 | -92.78 | -48.15 |
23Q4 (17) | 0.70 | 59.09 | 42.86 | 0.54 | 54.29 | 28.57 | 1.94 | 55.2 | 17.58 |
23Q3 (16) | 0.44 | -18.52 | -4.35 | 0.35 | -16.67 | -7.89 | 1.25 | 54.32 | 7.76 |
23Q2 (15) | 0.54 | 100.0 | 25.58 | 0.42 | 121.05 | 10.53 | 0.81 | 200.0 | 15.71 |
23Q1 (14) | 0.27 | -44.9 | 0.0 | 0.19 | -54.76 | -29.63 | 0.27 | -83.64 | 0.0 |
22Q4 (13) | 0.49 | 6.52 | -5.77 | 0.42 | 10.53 | -16.0 | 1.65 | 42.24 | -6.25 |
22Q3 (12) | 0.46 | 6.98 | -16.36 | 0.38 | 0.0 | -24.0 | 1.16 | 65.71 | -6.45 |
22Q2 (11) | 0.43 | 59.26 | 2.38 | 0.38 | 40.74 | 0.0 | 0.70 | 159.26 | 1.45 |
22Q1 (10) | 0.27 | -48.08 | -3.57 | 0.27 | -46.0 | 0.0 | 0.27 | -84.66 | -3.57 |
21Q4 (9) | 0.52 | -5.45 | -34.18 | 0.50 | 0.0 | -35.06 | 1.76 | 41.94 | -28.16 |
21Q3 (8) | 0.55 | 30.95 | 3.77 | 0.50 | 31.58 | 8.7 | 1.24 | 79.71 | -25.3 |
21Q2 (7) | 0.42 | 50.0 | -4.55 | 0.38 | 40.74 | -9.52 | 0.69 | 146.43 | -38.94 |
21Q1 (6) | 0.28 | -64.56 | -59.42 | 0.27 | -64.94 | -63.01 | 0.28 | -88.57 | -59.42 |
20Q4 (5) | 0.79 | 49.06 | 107.89 | 0.77 | 67.39 | 83.33 | 2.45 | 47.59 | 11.87 |
20Q3 (4) | 0.53 | 20.45 | 0.0 | 0.46 | 9.52 | 0.0 | 1.66 | 46.9 | 0.0 |
20Q2 (3) | 0.44 | -36.23 | 0.0 | 0.42 | -42.47 | 0.0 | 1.13 | 63.77 | 0.0 |
20Q1 (2) | 0.69 | 81.58 | 0.0 | 0.73 | 73.81 | 0.0 | 0.69 | -68.49 | 0.0 |
19Q4 (1) | 0.38 | 0.0 | 0.0 | 0.42 | 0.0 | 0.0 | 2.19 | 0.0 | 0.0 |
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/10 | 0.26 | 26.65 | 17.31 | 2.35 | 14.51 | 0.74 | N/A | - | ||
2024/9 | 0.2 | -27.82 | -6.08 | 2.09 | 14.17 | 0.69 | 0.22 | - | ||
2024/8 | 0.28 | 40.19 | 34.15 | 1.88 | 16.9 | 0.96 | 0.16 | - | ||
2024/7 | 0.2 | -57.64 | 18.28 | 1.6 | 14.31 | 0.92 | 0.16 | - | ||
2024/6 | 0.48 | 98.71 | 30.03 | 1.4 | 13.76 | 0.92 | 0.17 | - | ||
2024/5 | 0.24 | 15.05 | 6.5 | 0.92 | 6.88 | 0.61 | 0.26 | - | ||
2024/4 | 0.21 | 24.14 | 39.46 | 0.69 | 7.01 | 0.53 | 0.3 | - | ||
2024/3 | 0.17 | 11.05 | -18.85 | 0.48 | -2.84 | 0.48 | 0.8 | - | ||
2024/2 | 0.15 | -4.98 | -26.38 | 0.31 | 8.77 | 0.66 | 0.57 | - | ||
2024/1 | 0.16 | -55.21 | 99.2 | 0.16 | 99.2 | 0.76 | 0.5 | 因去年1月適逢農曆春節工作天數較少,故營業額較去年同期增加所致。 | ||
2023/12 | 0.35 | 45.13 | 32.34 | 2.65 | 12.21 | 0.82 | 0.31 | - | ||
2023/11 | 0.24 | 11.03 | -8.25 | 2.29 | 9.63 | 0.68 | 0.37 | - | ||
2023/10 | 0.22 | 1.39 | 38.03 | 2.05 | 12.24 | 0.65 | 0.39 | - | ||
2023/9 | 0.22 | 3.1 | 12.38 | 1.83 | 9.77 | 0.6 | 0.3 | - | ||
2023/8 | 0.21 | 23.6 | -3.72 | 1.61 | 9.43 | 0.75 | 0.24 | - | ||
2023/7 | 0.17 | -53.43 | -8.34 | 1.4 | 11.72 | 0.76 | 0.24 | - | ||
2023/6 | 0.37 | 62.75 | 61.08 | 1.23 | 15.21 | 0.74 | 0.16 | 本月儀器設備銷售額增加 | ||
2023/5 | 0.22 | 50.66 | 25.35 | 0.86 | 2.83 | 0.58 | 0.21 | - | ||
2023/4 | 0.15 | -27.77 | -5.19 | 0.64 | -3.26 | 0.56 | 0.21 | - | ||
2023/3 | 0.21 | 0.75 | -5.67 | 0.49 | -2.65 | 0.49 | 0.33 | - | ||
2023/2 | 0.2 | 157.13 | 32.84 | 0.28 | -0.34 | 0.55 | 0.29 | - | ||
2023/1 | 0.08 | -70.25 | -39.32 | 0.08 | -39.32 | 0.61 | 0.26 | - | ||
2022/12 | 0.27 | 0.61 | 46.83 | 2.36 | 3.66 | 0.69 | 0.22 | - | ||
2022/11 | 0.27 | 67.03 | 14.25 | 2.09 | -0.1 | 0.62 | 0.24 | - | ||
2022/10 | 0.16 | -17.44 | -6.35 | 1.82 | -1.9 | 0.57 | 0.26 | - | ||
2022/9 | 0.19 | -11.67 | -5.54 | 1.67 | -1.45 | 0.6 | 0.23 | - | ||
2022/8 | 0.22 | 17.67 | 5.22 | 1.47 | -0.88 | 0.63 | 0.22 | - | ||
2022/7 | 0.19 | -18.17 | -0.05 | 1.25 | -1.88 | 0.59 | 0.24 | - | ||
2022/6 | 0.23 | 26.65 | 16.25 | 1.07 | -2.19 | 0.56 | 0.25 | - | ||
2022/5 | 0.18 | 13.94 | 13.41 | 0.84 | -6.21 | 0.56 | 0.25 | - | ||
2022/4 | 0.16 | -28.13 | -37.03 | 0.66 | -10.4 | 0.53 | 0.26 | - | ||
2022/3 | 0.22 | 41.9 | 4.4 | 0.5 | 3.19 | 0.5 | 0.24 | - | ||
2022/2 | 0.15 | 17.44 | 23.96 | 0.29 | 2.28 | 0.47 | 0.26 | - | ||
2022/1 | 0.13 | -28.0 | -15.14 | 0.13 | -15.14 | 0.55 | 0.22 | - | ||
2021/12 | 0.18 | -21.7 | -41.69 | 2.28 | -23.85 | 0.59 | 0.19 | - | ||
2021/11 | 0.23 | 36.91 | 2.52 | 2.09 | -21.76 | 0.61 | 0.18 | - | ||
2021/10 | 0.17 | -16.73 | -44.2 | 1.86 | -24.02 | 0.58 | 0.19 | - | ||
2021/9 | 0.2 | -1.61 | -15.87 | 1.69 | -21.15 | 0.6 | 0.22 | - | ||
2021/8 | 0.21 | 11.77 | -1.47 | 1.49 | -21.82 | 0.59 | 0.22 | - | ||
2021/7 | 0.19 | -4.8 | -6.4 | 1.28 | -24.36 | 0.54 | 0.24 | - | ||
2021/6 | 0.2 | 23.55 | 13.41 | 1.09 | -26.75 | 0.6 | 0.17 | - | ||
2021/5 | 0.16 | -36.73 | -24.12 | 0.9 | -32.0 | 0.62 | 0.16 | - | ||
2021/4 | 0.25 | 19.14 | 25.38 | 0.74 | -33.47 | 0.58 | 0.17 | - | ||
2021/3 | 0.21 | 68.47 | -46.15 | 0.49 | -46.34 | 0.49 | 0.31 | - | ||
2021/2 | 0.12 | -19.6 | -67.69 | 0.28 | -46.49 | 0.59 | 0.25 | 因去年同期儀器設備銷售額增加,導致本月較去年同期營收減少 | ||
2021/1 | 0.15 | -50.52 | 13.19 | 0.15 | 13.19 | 0.7 | 0.22 | - | ||
2020/12 | 0.31 | 37.66 | 55.78 | 2.99 | -13.78 | 0.85 | 0.17 | 因本月儀器設備銷售額增加,導致本月營收較去年同期增加 | ||
2020/11 | 0.23 | -25.49 | -2.54 | 2.68 | -18.06 | 0.78 | 0.18 | - | ||
2020/10 | 0.31 | 25.55 | 56.08 | 2.45 | -19.26 | 0.76 | 0.18 | 因取得客戶之儀器設備訂單於10月完成驗收,導致本月營收增加 | ||
2020/9 | 0.24 | 15.23 | 29.38 | 2.14 | -24.45 | 0.65 | 0.32 | - | ||
2020/8 | 0.21 | 6.17 | 1.59 | 1.9 | -28.26 | 0.58 | 0.36 | - | ||
2020/7 | 0.2 | 15.35 | -8.04 | 1.69 | -30.8 | 0.58 | 0.36 | - | ||
2020/6 | 0.17 | -17.34 | -7.19 | 1.49 | -33.01 | 0.58 | 0.26 | - | ||
2020/5 | 0.21 | 4.54 | -72.24 | 1.32 | -35.36 | 0.8 | 0.19 | 因去年同期客戶新建醫療園區購置相關儀器設備陸續結案所致 | ||
2020/4 | 0.2 | -48.83 | -57.64 | 1.11 | -13.9 | 0.97 | 0.15 | 因去年同期生技園區實驗動物相關儀器設備需求增加所致 | ||
2020/3 | 0.39 | 1.08 | 90.07 | 0.91 | 11.2 | 0.91 | 0.16 | 因取得客戶之儀器設備訂單於3月完成驗收,導致本月營收增加 | ||
2020/2 | 0.39 | 181.67 | 1.56 | 0.52 | -15.08 | 0.72 | 0.21 | - | ||
2020/1 | 0.14 | -31.91 | -41.91 | 0.14 | -41.91 | 0.57 | 0.26 | - | ||
2019/12 | 0.2 | -13.88 | -34.55 | 3.47 | 18.03 | 0.0 | N/A | - | ||
2019/11 | 0.23 | 19.32 | 32.18 | 3.27 | 24.17 | 0.0 | N/A | - |